Compare IBRX & GOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBRX | GOLF |
|---|---|---|
| Founded | 2014 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 4.9B |
| IPO Year | 2015 | 2016 |
| Metric | IBRX | GOLF |
|---|---|---|
| Price | $7.94 | $93.06 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | $12.57 | ★ $83.67 |
| AVG Volume (30 Days) | ★ 31.4M | 364.9K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.10% |
| EPS Growth | ★ 38.71 | N/A |
| EPS | N/A | ★ 3.11 |
| Revenue | $113,288,000.00 | ★ $1,633,721,000.00 |
| Revenue This Year | $88.57 | $5.01 |
| Revenue Next Year | $146.98 | $3.57 |
| P/E Ratio | ★ N/A | $29.88 |
| Revenue Growth | ★ 668.31 | 4.71 |
| 52 Week Low | $1.83 | $55.31 |
| 52 Week High | $12.43 | $104.81 |
| Indicator | IBRX | GOLF |
|---|---|---|
| Relative Strength Index (RSI) | 49.64 | 36.44 |
| Support Level | $2.27 | $75.65 |
| Resistance Level | $8.28 | $104.16 |
| Average True Range (ATR) | 1.03 | 3.28 |
| MACD | -0.33 | -1.17 |
| Stochastic Oscillator | 3.33 | 17.49 |
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, and others. These products are offered through different brands such as Titleist, FootJoy, Scotty Cemeron, Vokey Design, Pinnacle, KJUS, and others. The company's reportable segments are Titleist golf equipment, FootJoy golf wear, and Gofl gear. A majority of its revenue is generated by the Titleist golf equipment segment. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Asia (EMEA), Japan, Korea, and the Rest of the world.